Mechanisms of action of CHF3381 in the forebrain-Reference-Cited by-同舟云学术

Mechanisms of action of CHF3381 in the forebrain

Published:2003-08 Issue:7 Volume:139 Page:1333-1341
ISSN:0007-1188
Container-title:British Journal of Pharmacology
language:en
Short-container-title:

Author:

Barbieri Mario,Bregola Gianni,Buzzi Andrea,Marino Silvia,Zucchini Silvia,Stables James P,Bergamaschi Marco,Pietra Claudio,Villetti Gino,Simonato Michele

Publisher

Wiley

Subject

Pharmacology

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1038/sj.bjp.0705381/fullpdf

Reference27 articles.

1. Noradrenaline inhibition of acetylcholine release from guinea-pig brain;BEANI;Eur. J. Pharmacol.,1978

2. Anticonvulsant preclinical profile of CHF 3381: dopaminergic and glutamatergic mechanisms;GANDOLFI;Pharmacol. Biochem. Behav.,2001

3. Improved patch-clamp techniques for high-resolution current recording from cells and cell-free membrane patches;HAMILL;Pflugers Arch.,1981

4. Differences in the anatomic distribution of immediate-early gene expression in amygdala and angular bundle kindling development;HOSFORD;J. Neurosci.,1995

5. Activity and injury-dependent expression of inducible transcription factors, growth factors and apoptosis-related genes within the central nervous system;HUGHES;Prog. Neurobiol.,1999

Cited by 6 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Ion channel blockers for the treatment of neuropathic pain;Future Medicinal Chemistry;2010-05

2. CHF3381, a N-methyl-D-aspartate Receptor Antagonist and Monoamine Oxidase–A Inhibitor, Attenuates Secondary Hyperalgesia in a Human Pain Model;The Journal of Pain;2006-08

3. Synthesis and anticonvulsant activity of a class of 2-amino 3-hydroxypropanamide and 2-aminoacetamide derivatives;Bioorganic & Medicinal Chemistry;2006-05

4. Anticonvulsant and Behavioural Effects of the Denatured Venom of the Social Wasp Polybia occidentalis (Polistinae, Vespidae);Basic Clinical Pharmacology Toxicology;2005-11

5. Steady-state pharmacokinetics and pharmacodynamics of CHF3381, a novel antineuropathic pain agent, in healthy subjects;British Journal of Clinical Pharmacology;2005-04